Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening

Transfusion ◽  
2008 ◽  
Vol 48 (4) ◽  
pp. 584-593 ◽  
Author(s):  
Eva Sickinger ◽  
Gesa Jonas ◽  
Alex W. Yem ◽  
Andreas Goller ◽  
Myriam Stieler ◽  
...  
2006 ◽  
Vol 133 (1) ◽  
pp. 20-26 ◽  
Author(s):  
Jung-Ah Kwon ◽  
Soo-Young Yoon ◽  
Chang-Kyu Lee ◽  
Chae Seung Lim ◽  
Kap No Lee ◽  
...  

2017 ◽  
Vol 50 (4) ◽  
pp. 440-447 ◽  
Author(s):  
Chun-Kai Chang ◽  
Cheng-Feng Kao ◽  
Pi-Han Lin ◽  
Hui-Lin Huang ◽  
Shu-Yuan Ho ◽  
...  

2018 ◽  
Vol 40 (2) ◽  
pp. 92-100
Author(s):  
Dong Hee Seo ◽  
Yeo Rin Choi ◽  
Won Woong Choi ◽  
Cheol Hee Yoon ◽  
Byeong Sun Choi ◽  
...  

2015 ◽  
Vol 3 (1) ◽  
Author(s):  
Laura G. Wesolowski ◽  
Muazzam Nasrullah ◽  
Robert W. Coombs ◽  
Eric Rosenberg ◽  
Steven F. Ethridge ◽  
...  

Abstract Background.  To improve clinical and public health outcomes through early human immunodeficiency virus (HIV) detection, fourth-generation antigen/antibody immunoassay (4IA) and supplemental testing results must be returned rapidly. Methods.  We examined HIV testing data at Harborview Medical Center (HMC), Massachusetts General Hospital (MGH), and the Medical University of South Carolina (MUSC), which used 4IA and supplemental antibody and nucleic acid tests (NATs). At MGH and MUSC, HIV-1 Western blot (WB) and HIV-2 testing were conducted at a reference laboratory. We compared time from specimen collection to laboratory result for established (positive WB) and acute infections (reactive 4IA, negative/indeterminate WB, detectable NAT), and we calculated testing cost per positive-test result. Results.  From 3731 (MUSC) to 19 774 (MGH) tests were conducted; 0.01% (MGH) to 0.05% (HMC) were acute infections. Each laboratory had reactive 4IA, WB-negative, or indeterminate specimens without NAT (ie, potential acute infections). Time to result was 1.5 (HMC) to 5.2 days (MGH) for acute and 1.0 (HMC) to 5.2 days (MGH) for established infections. Costs were $1054 (MGH) to $1521 (MUSC). Conclusions.  Conducting supplemental testing in-house lowered turnaround times, which may be further reduced with rapid HIV-1/HIV-2 differentiation tests. Hospitals may benefit from quantitative NATs not requiring physician orders, so all potential acute infections receive NAT.


1987 ◽  
Vol 84 (11) ◽  
pp. 3876-3880 ◽  
Author(s):  
J. Goudsmit ◽  
L. G. Epstein ◽  
D. A. Paul ◽  
H. J. van der Helm ◽  
G. J. Dawson ◽  
...  

2013 ◽  
Vol 87 (4) ◽  
pp. 415-423 ◽  
Author(s):  
Takako SANO ◽  
Makiko KONDO ◽  
Yukihiro YOSHIMURA ◽  
Natsuo TACHIKAWA ◽  
Hiroko SAGARA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document